Kepler Vision Technologies Reports New Partnership

Kepler Vision Technologies continues to extend its reach across Europe by partnering with Norwegian company OneCo Technology. OneCo Technology, is a leader in cutting-edge technology solutions, and Kepler Vision, a renowned healthcare service provider with a deep understanding of local requirements, have joined forces to create a synergy that promises to revolutionise the way healthcare is delivered and managed in Norway.

The care industry is facing increasingly difficult challenges due to an aging population and workforce. While the population of 65+ continues to grow, the workforce sustaining care for this demographic is shrinking. At the core of this collaboration is the integration of advanced technologies into the existing healthcare infrastructure. Kepler Vision’s state-of-the-art innovations in artificial intelligence and digital healthcare solutions are seamlessly merging with OneCo Technology’s extensive experience in patient care, clinical workflows, and operational efficiency.

With the rise of AI, there has been a rapid acceptance of its benefits and use – albeit with some trepidation. With AI still in its infancy stage, there is much more room for growth. Both companies boast a wealth of experience and a passion for pushing boundaries that will lead to the development of innovative solutions that will undoubtedly set new benchmarks within the industry.

Utilising AI and computer vision learnings, Kepler Vision’s Night Nurse solution brings an exceptionally reliable fall detector. Pair this with OneCo’s expertise in patient care and there is potential for significantly improved patient outcomes and experiences.

This is the latest partnership that joins Kepler’s ever expanding network. It’s smart sensor technology is currently embedded in the Mobotix C71 camera but can be run with on any camera using on-premise servers. The product is being used in 8 European countries and is supported by Alcatel Lucent, KPN Health, Ascom, and others. Most recently, the health-tech company partnered with Yourizon, which added Kepler’s technology into its own product line.

Lene Høysæter Larsen, Head of Health Technology and Corporate Communications says: “This partnership between OneCo and Kepler is not just a collaboration; it’s a declaration of intent—a commitment to shaping the future of technology and data analytics. This alliance brings together the best of both worlds, fusing technological innovation with data-driven insights to empower businesses and drive unparalleled success.”

Harro Stokman, CEO of Kepler Vision Technologies says: “Working with companies like OneCo Technology provide so many benefits to not just eachother’s companies but also the patients and care workers using our products. As we continue to meet and collaborate with more innovative companies like OneCo across Europe, we can expect even better solutions to be developed.”

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.